SkinBioTherapeutics Plc (SBTX.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 38.28M |
| Enterprise Value | 34.5M |
| P/E Ratio | -63.89 |
| PEG Ratio | -0.42 |
| Price/Sales Ratio | 5.7 |
| Price/Book Ratio | 3.73 |
| Enterprise/Revenue | 5.28 |
| Enterprise/EBITDA | -278.2 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.09 |
| Operating Margin | -0.21 |
AD
Management Effectiveness
| Return On Assets | -0.05 |
| Return On Equity | -0.05 |
Income Statement
| Revenue | 4.64M |
| Revenue/Share | 0.02 |
| Gross Profit | 2.71M |
| EBITDA | -196,540 |
| Net Income | -696,253 |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 3.12M |
| Total Cash/Share | 0.01 |
| Total Debt | 939,165 |
| Total Debt/Equity | 0.12 |
| Current Ratio | 6.14 |
| Book Value Per Share | 0.03 |
Price History
| 52-Week Change | -30.3 |
| 52-Week High | 23 |
| 52-Week Low | 0.1 |
| Moving Average 50 Days | 4.64 |
| Moving Average 200 Days | 11.65 |
Statistics
| Average Volume | 512,702 |
| Shares Outstanding | 259.17M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
